Top Startups that are Building Tools for Life Sciences

Life Sciences is an emerging industry focused on the pursuit of better understanding mechanisms of disease and finding potential treatments.

Many of today’s modern life science startups are biotech companies. These companies are using advanced technology to create solutions that address today’s health concerns. Are you interested to learn which biotech companies are worth investing in? Or, are you simply intrigued to learn more about today’s up-and-coming companies? If so, you’ve come to the right place.

 

Most successful life science companies have one thing in common: strong growth of earnings. Using this as a measure of the startups you should be looking out for, we’ve created a list that indicates startups that are building for a significant future.

Here are some of the top startups who are building tools for life sciences:

Synthego

Anima Biotech

As a company that’s focused on advanced Translation Control Therapeutics, Anima appears set for a promising future. Specifically, the company’s research is focused on developing drugs that control mRNA translation.

This work has a wide-ranging industry impact, with the potential to help thousands of people. Anima has been developing a strategy against undruggable targets in diseases, which is why it’s so interesting to see their industry concept unfold.

Avectas

This company delivers advanced molecules such as mRNA and gene editing payloads for cell engineering and proteins. It delivers tools to a variety of cell types with immuno-oncology applications.

Avectas has made it possible for drug developers to manufacture engineered cell therapies with therapeutic effects, causing minimal cell disruption and generating maximum efficiency. In addition, the company is leveraging a vector-free cell engineering technology known as Solupore. This tool allows a more cost-effective, simpler and shorter gene-editing process. This supersedes the present industry standard of vector-free delivery methods, such as electroporation.

Capio Biosciences

Capio Biosciences has leveraged over 10 years of R&D in hematology and circulating tumor cell (CTC) analysis to simplify oncology diagnostics. The company’s research and development efforts have played an important role in its success.

This startup has developed a flagship product that utilizes centrifuged blood samples to isolate white blood cells and CTCs. These are put through a flow chamber system, where they travel across the Capio Biosciences’ proprietary chips to induce cell rolling, enhancing the capture efficiency of CTCs.

inRegen

inRegen has developed a therapy known as REACT (Regenerative Advanced Cell Therapy), which is designed to improve renal function. The therapy is used to treat individuals with kidney disease.

REACT harnesses the power of the human body to repair damaged kidney tissues, improving kidney functioning, regenerating tissues and stabilizing kidney cells.

This novel therapy is more effective than kidney transplants or dialysis while minimizing side effects or rejection from the host body.

transplants or dialysis

QuantumCyte

QuantumCyte is a biotech startup developing tools within the single-cell community. Specifically, the company is focused on analysis and research, having already developed an original overview of the interrogation and isolation of cancer cells.

Notably, QuantumCyte can speed up the transition from patient biopsy to actionable data by 75%. The company is a key contributor within the medical science, life science and biotechnology communities. Their single-cell analysis, immunophenotyping, RNA extraction, and immune repertoire are pioneering medical research.

Synthego

This startup is an innovative biotech startup on a mission to accelerate the discovery of modern cures. Synthego plans to widen the access of CPISPR, building advanced abioinformatics to create impressive biology tools for life sciences. The company’s main focus is full-stack genome engineering, where machine learning can be applied to produce budget-friendly, consistent results. Through the development of these innovativet technologies, Synthego is fully committed to unlocking the true potential of genome editing.

biotechnology communities

Contact us

If you have any comments or suggestions, please do not hesitate to contact us